Cure Meds Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 7.67%
- Profit Growth 3350.59%
- Ebitda 151.94%
- Net Worth 15.64%
- Total Assets -4.03%
About Cure Meds
Cure Meds Private Limited (CMPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 December 2015 (Nine years and two months 2 days old ). Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pranav Agarwal, Seema Khanna, and Kareshma Khanna serve as directors at the Company.
Company Details
-
Location
Lucknow, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233UP2015PTC074952
-
Company No.
074952
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Dec 2015
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Cure Meds?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pranav Agarwal
|
Additional Director | 01-Apr-2020 | Current |
|
Seema Khanna
|
Director | 09-Dec-2015 | Current |
|
Kareshma Khanna
|
Director | 31-Jul-2018 | Current |
Financial Performance of Cure Meds.
Cure Meds Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 7.67% increase. The company also saw a substantial improvement in profitability, with a 3350.59% increase in profit. The company's net worth Soared by an impressive increase of 15.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cure Meds?
Unlock access to Cure Meds's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Kaps Developers Private LimitedPranav Agarwal is a mutual person
-
Tape -A- Tale Solutions Private LimitedSeema Khanna is a mutual person
-
Kaps Medequip Private LimitedPranav Agarwal is a mutual person
-
Sri Harkrishan Colonisers & Promoters Private Limited
Seema Khanna and Kareshma Khanna are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cure Meds?
Unlock and access historical data on people associated with Cure Meds, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cure Meds, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cure Meds's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
